x

Neumora Therapeutics, Inc. (Nasdaq:NMRA)

Health Care/Life Sciences • Biotechnology
CIK 1885522
Company

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.

Address
490 Arsenal Way
Suite 200
Watertown, Massachusetts 02472
Employees
124
Stock Info
Close
$1.4300
Day Range
1.3700 - 1.4500
52 Week Range
1.3500 - 21.0000
Average volume
3.04M
Short Interest
11.2M (02/14/25)
% of Float Shorted
20.00%
Market Cap
$231.63M
Revenue
N/A
Net Income
-$235.93M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.5263
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman & Chief Executive Officer
Paul L. Berns
Director
Kristina Marie Burow
Director
Matthew K. Fust
Director
David A. Piacquad
Director
May Kin Ho
Director
Alaa Halawa
SEC filings
DateFormEvent
22 Nov, 2024 SC 13D/A
12 Nov, 2024 SC 13G
12 Nov, 2024 8-K
12 Nov, 2024 10-Q
18 Oct, 2024 4
18 Oct, 2024 144
17 Oct, 2024 144
11 Oct, 2024 4
10 Oct, 2024 144
9 Oct, 2024 144
1 Oct, 2024 S-3ASR
19 Sep, 2024 4
18 Sep, 2024 144
17 Sep, 2024 144
16 Sep, 2024 4
13 Sep, 2024 4
12 Sep, 2024 144
27 Aug, 2024 4
26 Aug, 2024 4
22 Aug, 2024 144
6 Aug, 2024 10-Q
6 Aug, 2024 8-K
8 Jul, 2024 SCHEDULE 1
8 Jul, 2024 SCHEDULE 1
28 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 8-K
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
7 May, 2024 8-K
7 May, 2024 10-Q
25 Apr, 2024 DEF 14A
25 Apr, 2024 DEFA14A
24 Apr, 2024 4
15 Apr, 2024 8-K
7 Mar, 2024 8-K
7 Mar, 2024 S-8
7 Mar, 2024 10-K
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
14 Feb, 2024 SC 13G
13 Feb, 2024 SC 13G
8 Jan, 2024 8-K
15 Dec, 2023 SC 13D/A
12 Dec, 2023 4
12 Dec, 2023 4
12 Dec, 2023 3
12 Dec, 2023 4
12 Dec, 2023 4
28 Nov, 2023 8-K
15 Nov, 2023 4
15 Nov, 2023 4
13 Nov, 2023 4
13 Nov, 2023 4
7 Nov, 2023 4
7 Nov, 2023 4
1 Nov, 2023 8-K
1 Nov, 2023 10-Q
2 Oct, 2023 SC 13D
29 Sep, 2023 4
29 Sep, 2023 4
27 Sep, 2023 4
27 Sep, 2023 4
27 Sep, 2023 SC 13D
25 Sep, 2023 4
25 Sep, 2023 4
21 Sep, 2023 4
20 Sep, 2023 S-8
20 Sep, 2023 4
20 Sep, 2023 4
20 Sep, 2023 4
19 Sep, 2023 4
19 Sep, 2023 4
19 Sep, 2023 8-K
18 Sep, 2023 4
18 Sep, 2023 4
18 Sep, 2023 4
18 Sep, 2023 424B4 IPO completed
18 Sep, 2023 3
18 Sep, 2023 4
18 Sep, 2023 4
18 Sep, 2023 4
14 Sep, 2023 3
14 Sep, 2023 SEC STAFF
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 EFFECT
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 3
14 Sep, 2023 CERT
14 Sep, 2023 3
13 Sep, 2023 8-A12B
12 Sep, 2023 CORRESP
12 Sep, 2023 CORRESP
11 Sep, 2023 S-1/A
25 Aug, 2023 S-1
25 Aug, 2023 CORRESP
17 Aug, 2023 UPLOAD
9 Aug, 2023 DRS/A
8 Aug, 2023 DRSLTR
12 Jul, 2023 UPLOAD
30 Jun, 2023 DRSLTR
30 Jun, 2023 DRS/A
24 May, 2023 SEC STAFF
24 May, 2023 UPLOAD
2 May, 2023 DRS/A
3 Jan, 2023 D
2 Sep, 2022 DRS/A
2 Sep, 2022 DRSLTR
17 Jun, 2022 UPLOAD
10 Jun, 2022 DRS/A
10 Jun, 2022 DRSLTR
16 May, 2022 UPLOAD
2 May, 2022 DRS/A
14 Feb, 2022 DRS/A
11 Feb, 2022 DRSLTR
7 Jan, 2022 UPLOAD
23 Dec, 2021 DRS/A
22 Dec, 2021 DRSLTR
6 Dec, 2021 UPLOAD
8 Nov, 2021 DRS
Last update:2025-03-06 12:19:30.297149
Neumora Therapeutics, Inc. by TradingView

Sign Up to Subscribe